Interparfums Inc header image

Interparfums Inc

IPAR

Equity

ISIN null / Valor 833467

NASDAQ (2026-02-20)
USD 103.41+2.23%

Interparfums Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Inter Parfums, Inc., established in 1982, operates within the global fragrance industry, specializing in the production and distribution of an extensive range of prestige fragrance and fragrance-related products. The company conducts its operations through two main segments: European operations, managed by its 72% owned subsidiary Interparfums SA, and United States-based operations. Inter Parfums holds license agreements with various brand owners, producing and distributing products for a portfolio of prestige brands such as Boucheron, Coach, Jimmy Choo, and Montblanc, among others. These products are available in over 120 countries. European operations account for approximately 65% of the company's net sales, with the remaining 35% generated by its U.S. operations, which include brands like Abercrombie & Fitch, Anna Sui, and Donna Karan. The company focuses on leveraging the strong market presence of these brands, introducing new fragrance families every few years alongside seasonal and limited-edition fragrances to maintain consumer interest and market relevance.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-23.2%1Y
-12.5%3Y
50.3%5Y

Performance

32.5%1Y
33.4%3Y
33.6%5Y

Volatility

Market cap

3316 M

Market cap (USD)

Daily traded volume (Shares)

179,187

Daily traded volume (Shares)

1 day high/low

130.95 / 127.9

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Conmed Corp
Conmed Corp Conmed Corp Valor: 920278
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.28%USD 45.14
National Healthcare Corp
National Healthcare Corp National Healthcare Corp Valor: 836282
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.38%USD 157.82
Dexcom Inc
Dexcom Inc Dexcom Inc Valor: 2107726
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.12%USD 73.08
Align Technology Inc
Align Technology Inc Align Technology Inc Valor: 1159441
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.33%USD 190.02
Insulet Corp
Insulet Corp Insulet Corp Valor: 2941247
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.89%USD 241.89
Henry Schein Inc
Henry Schein Inc Henry Schein Inc Valor: 83527
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.61%USD 79.57
NovoCure Limited
NovoCure Limited NovoCure Limited Valor: 29570025
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.26%USD 11.36
Roivant Sciences Limited
Roivant Sciences Limited Roivant Sciences Limited Valor: 113331044
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.34%USD 27.15
Integra Lifesciences Holdings Corp
Integra Lifesciences Holdings Corp Integra Lifesciences Holdings Corp Valor: 912247
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.33%USD 12.21
ICU Medical Inc
ICU Medical Inc ICU Medical Inc Valor: 940704
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.87%USD 157.03